671 related articles for article (PubMed ID: 21439797)
1. Factors affecting drug encapsulation and stability of lipid-polymer hybrid nanoparticles.
Cheow WS; Hadinoto K
Colloids Surf B Biointerfaces; 2011 Jul; 85(2):214-20. PubMed ID: 21439797
[TBL] [Abstract][Full Text] [Related]
2. Vitamin E TPGS-emulsified poly(lactic-co-glycolic acid) nanoparticles for cardiovascular restenosis treatment.
Feng SS; Zeng W; Teng Lim Y; Zhao L; Yin Win K; Oakley R; Hin Teoh S; Hang Lee RC; Pan S
Nanomedicine (Lond); 2007 Jun; 2(3):333-44. PubMed ID: 17716178
[TBL] [Abstract][Full Text] [Related]
3. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.
Feng SS; Mei L; Anitha P; Gan CW; Zhou W
Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012
[TBL] [Abstract][Full Text] [Related]
4. Lysozyme-loaded lipid-polymer hybrid nanoparticles: preparation, characterization and colloidal stability evaluation.
Devrim B; Kara A; Vural İ; Bozkır A
Drug Dev Ind Pharm; 2016 Nov; 42(11):1865-76. PubMed ID: 27091346
[TBL] [Abstract][Full Text] [Related]
5. A comparison between spray drying and spray freeze drying for dry powder inhaler formulation of drug-loaded lipid-polymer hybrid nanoparticles.
Wang Y; Kho K; Cheow WS; Hadinoto K
Int J Pharm; 2012 Mar; 424(1-2):98-106. PubMed ID: 22226876
[TBL] [Abstract][Full Text] [Related]
6. Formulation and optimization of nonionic surfactants emulsified nimesulide-loaded PLGA-based nanoparticles by design of experiments.
Turk CT; Oz UC; Serim TM; Hascicek C
AAPS PharmSciTech; 2014 Feb; 15(1):161-76. PubMed ID: 24222270
[TBL] [Abstract][Full Text] [Related]
7. Influence of microencapsulation method and peptide loading on formulation of poly(lactide-co-glycolide) insulin nanoparticles.
Kumar PS; Ramakrishna S; Saini TR; Diwan PV
Pharmazie; 2006 Jul; 61(7):613-7. PubMed ID: 16889069
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of ciprofloxacin-loaded Eudragit RS100 or RL100/PLGA nanoparticles.
Dillen K; Vandervoort J; Van den Mooter G; Ludwig A
Int J Pharm; 2006 May; 314(1):72-82. PubMed ID: 16600538
[TBL] [Abstract][Full Text] [Related]
9. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
Hadinoto K; Sundaresan A; Cheow WS
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180
[TBL] [Abstract][Full Text] [Related]
10. Biodegradable levofloxacin nanoparticles for sustained ocular drug delivery.
Gupta H; Aqil M; Khar RK; Ali A; Bhatnagar A; Mittal G
J Drug Target; 2011 Jul; 19(6):409-17. PubMed ID: 20678034
[TBL] [Abstract][Full Text] [Related]
11. Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance.
Liu Y; Pan J; Feng SS
Int J Pharm; 2010 Aug; 395(1-2):243-50. PubMed ID: 20472049
[TBL] [Abstract][Full Text] [Related]
12. Design and optimization of NSAID loaded nanoparticles.
Sashmal S; Mukherjee S; Ray S; Thakur RS; Ghosh LK; Gupta BK
Pak J Pharm Sci; 2007 Apr; 20(2):157-62. PubMed ID: 17416573
[TBL] [Abstract][Full Text] [Related]
13. Folate-decorated hybrid polymeric nanoparticles for chemically and physically combined paclitaxel loading and targeted delivery.
Wang J; Liu W; Tu Q; Wang J; Song N; Zhang Y; Nie N; Wang J
Biomacromolecules; 2011 Jan; 12(1):228-34. PubMed ID: 21158381
[TBL] [Abstract][Full Text] [Related]
14. Practical preparation procedures for docetaxel-loaded nanoparticles using polylactic acid-co-glycolic acid.
Keum CG; Noh YW; Baek JS; Lim JH; Hwang CJ; Na YG; Shin SC; Cho CW
Int J Nanomedicine; 2011; 6():2225-34. PubMed ID: 22114486
[TBL] [Abstract][Full Text] [Related]
15. Smart lipid nanoparticles containing levofloxacin and DNase for lung delivery. Design and characterization.
Islan GA; Tornello PC; Abraham GA; Duran N; Castro GR
Colloids Surf B Biointerfaces; 2016 Jul; 143():168-176. PubMed ID: 27003467
[TBL] [Abstract][Full Text] [Related]
16. A novel controlled release formulation for the anticancer drug paclitaxel (Taxol): PLGA nanoparticles containing vitamin E TPGS.
Mu L; Feng SS
J Control Release; 2003 Jan; 86(1):33-48. PubMed ID: 12490371
[TBL] [Abstract][Full Text] [Related]
17. Paclitaxel loaded folic acid targeted nanoparticles of mixed lipid-shell and polymer-core: in vitro and in vivo evaluation.
Zhao P; Wang H; Yu M; Liao Z; Wang X; Zhang F; Ji W; Wu B; Han J; Zhang H; Wang H; Chang J; Niu R
Eur J Pharm Biopharm; 2012 Jun; 81(2):248-56. PubMed ID: 22446630
[TBL] [Abstract][Full Text] [Related]
18. Antibiotic polymeric nanoparticles for biofilm-associated infection therapy.
Cheow WS; Hadinoto K
Methods Mol Biol; 2014; 1147():227-38. PubMed ID: 24664837
[TBL] [Abstract][Full Text] [Related]
19. Controlled preparation and antitumor efficacy of vitamin E TPGS-functionalized PLGA nanoparticles for delivery of paclitaxel.
Wang G; Yu B; Wu Y; Huang B; Yuan Y; Liu CS
Int J Pharm; 2013 Mar; 446(1-2):24-33. PubMed ID: 23402977
[TBL] [Abstract][Full Text] [Related]
20. Optimization, in vitro-in vivo evaluation, and short-term tolerability of novel levofloxacin-loaded PLGA nanoparticle formulation.
Kumar G; Sharma S; Shafiq N; Khuller GK; Malhotra S
J Pharm Sci; 2012 Jun; 101(6):2165-76. PubMed ID: 22392918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
